Skip to main content
logo
Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
6.34
+0.13 (2.09%)
At close: Aug 7, 2026, 4:00 PM EDT
6.34
0.00 (-0.01%)
After-hours: Aug 7, 2026, 7:57 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Innovating, Developing & Commercializing Therapies Using Autologous TIL
263.50M164.07M1.19M--
Total
263.50M164.07M1.19M--

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
259.01M161.04M---
Rest of World
4.49M3.03M1.19M--
Total
263.50M164.07M1.19M--